Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Epitope mapping of humoral immunogenicity of orvacabtagene autoleucel shows an IgM response with minimal impact on CAR T cellular kinetics.

Molecular therapy. Advances·2026
Same author

Women in Pharmaceutical Sciences: Progress, Possibility, and Lasting Impact.

Pharmaceutical research·2026
Same author

Immunogenicity Assessment for siRNA Therapeutics: A Risk-Based Proposal for Event-Driven Testing.

The AAPS journal·2026
Same author

Summary of Research: Immunogenicity of Dupilumab in Adult and Pediatric Patients with Atopic Dermatitis.

Dermatology and therapy·2026
Same author

Improving Compliance With Safe Sleep Guidelines for Vulnerable Patients in a Community Safety Net Hospital Neonatal Intensive Care Unit.

Pediatric quality & safety·2026
Same author

Progress and promise of pharmacodynamic biomarkers: novel strategies and assay considerations in drug development.

Bioanalysis·2026
Same journal

Updated Recommendations for the Bioanalysis of Antibody-Drug Conjugates (ADC) from the ADC working group of the AAPS Bioanalytical Community.

The AAPS journal·2026
Same journal

In vivo Predictive Dissolution Test Using Biorelevant Bicarbonate Buffer for High-dose Free Acid Drug.

The AAPS journal·2026
Same journal

Whole-Body Pharmacokinetics of Ionizable Lipid, mRNA, and the Expressed Antibody following Intravenous Administration of mRNA-Loaded Lipid Nanoparticles.

The AAPS journal·2026
Same journal

Simple Hydrodynamic Molecular Weight Model for Rapid Assessment of Therapeutic Protein Oligomerization States in Formulation.

The AAPS journal·2026
Same journal

Guiding the Molnupiravir Tablet Formulation Using Physiologically Based Biopharmaceutics Modeling and Successfully Establishing Dissolution Safe Space.

The AAPS journal·2026
Same journal

Correction: Nanotechnology-enhanced Natural Products for Cancer Chemoprevention: Molecular Mechanisms and Clinical Translation.

The AAPS journal·2026
查看所有相关文章

相关实验视频

Updated: Jul 24, 2025

Detection of Antibodies That Neutralize the Cellular Uptake of Enzyme Replacement Therapies with a Cell-based Assay
07:52

Detection of Antibodies That Neutralize the Cellular Uptake of Enzyme Replacement Therapies with a Cell-based Assay

Published on: September 10, 2018

8.9K

中和抗体验证测试和报告协调.

Heather Myler1,2, João Pedras-Vasconcelos3, Todd Lester4

  • 1Bioanalytical and Biomarker Science and Technologies, Takeda, Cambridge, MA, 02139, USA. heather.myler@takeda.com.

The AAPS journal
|July 8, 2023
PubMed
概括
此摘要是机器生成的。

协调免疫性测定验证和中和抗体报告,简化了卫生当局的文件. 本指南针对基于细胞和非细胞方法的关键测试性能和报告挑战.

关键词:
美国食品药品监督管理局 FDA FDA抗药抗体 (ADA) 是一种抗药性抗体.免疫性 免疫性 免疫性中和抗体 (NAb) 的产生.监管指南 监管指南 监管指南验证验证的时间

更多相关视频

Optimization of a Quantitative Micro-neutralization Assay
10:09

Optimization of a Quantitative Micro-neutralization Assay

Published on: December 14, 2016

21.3K
In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
07:25

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

Published on: May 4, 2017

17.8K

相关实验视频

Last Updated: Jul 24, 2025

Detection of Antibodies That Neutralize the Cellular Uptake of Enzyme Replacement Therapies with a Cell-based Assay
07:52

Detection of Antibodies That Neutralize the Cellular Uptake of Enzyme Replacement Therapies with a Cell-based Assay

Published on: September 10, 2018

8.9K
Optimization of a Quantitative Micro-neutralization Assay
10:09

Optimization of a Quantitative Micro-neutralization Assay

Published on: December 14, 2016

21.3K
In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
07:25

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

Published on: May 4, 2017

17.8K

科学领域:

  • 生物制药开发 生物制药开发
  • 免疫学 免疫学 免疫学
  • 分析化学 分析化学

背景情况:

  • 不断变化的免疫性检测性能标准和不一致的验证工具造成了监管障碍.
  • 卫生当局和赞助商在解决与中和抗体检测文件相关的查询方面损失了大量时间.

研究的目的:

  • 提供协调的验证测试和报告策略,用于中和抗体检测.
  • 为应对基于细胞和非细胞的免疫原性测试所面临的具体挑战.
  • 为了促进卫生当局更顺利地提交监管文件.

主要方法:

  • 美国制药科学家协会治疗产品免疫性社区的行业和FDA的专家共识.
  • 开发关键试验验证参数的策略和工具.
  • 专注于基于细胞和非细胞的中和抗体测定评估.

主要成果:

  • 关于11个关键验证方面的详细指导,包括格式选择,切割点确定和试验验收标准.
  • 评估控制精度,灵敏度和特异性的策略.
  • 考虑药物和目标耐受性,样本稳定性和试验稳定性.

结论:

  • 统一的验证期望和数据报告对于有效的监管提交至关重要.
  • 提出的策略和工具为一致的免疫原性测试评估提供了一个框架.
  • 实施将减少备案查询,加速治疗产品的开发.